Applied Materials Earns Zacks Rank #2 as Earnings Estimates Hold Steady

โดย Zacks Investment Research·US·Read original
Summary · why it matters

Applied Materials is expected to post earnings of $4.05 per share for the current quarter, a year-over-year change of +86.6%, with the Zacks Consensus Estimate unchanged over the last 30 days. The consensus earnings estimate of $12.78 for the current fiscal year indicates a year-over-year change of +35.7% and has changed +0.5% over the last 30 days, while the next fiscal year's consensus estimate of $18.3 indicates a change of +43.2% and has moved +0.7% over the past month. On the revenue side, the consensus sales estimate of $10.29 billion for the current quarter points to a year-over-year change of +51.3%, and the $34.23 billion and $45.74 billion estimates for the current and next fiscal years indicate changes of +20.7% and +33.6%, respectively. Applied Materials reported revenues of $9.12 billion in the last reported quarter, a year-over-year change of +24.8%, with EPS of $3.5 versus $2.48 a year ago, beating the Zacks Consensus Estimate of $9 billion by a revenue surprise of +1.31% and an EPS surprise of +3.55%. Based on the size of the recent change in the consensus estimate along with three other factors related to earnings estimates, Applied Materials is rated Zacks Rank #2 (Buy), though it is graded D on the Zacks Value Style Score, indicating it trades at a premium to its peers.

Impact on assets 1

Semiconductors · 1 stocks
Applied Materials Inc
AMAT
▲ PositiveCapitalrelevance

Applied Materials earns Zacks Rank #2 (Buy) with steady consensus earnings estimates and strong expected EPS/revenue growth.

Theme Impact 1

Related news

Yuanta Securities Expects LRCX19 Profit to Grow 62% in 2027 on AI Expansion

Yuanta Securities views Lam Research Corporation, or DR LRCX19, as one of the beneficiaries of rising demand for NAND flash memory, especially as AI usage expands from model training toward broader real-world deployment. Lam Research derives a relatively large share of revenue from equipment used to produce NAND, while revenue from equipment for DRAM memory chips is also supported by growing demand for advanced chips, namely the stacking of DRAM into HBM, a technology in which Lam Research already has expertise. In the short term, improving US-China relations could also be a supporting factor for the company, since it generates a high proportion of revenue from China and had previously been restricted from selling certain types of equipment to Chinese customers. The meeting between Trump and Xi Jinping could fuel short-term speculative interest. For the earnings outlook for fiscal year 2027, which ends in June 2027, the Bloomberg Consensus expects normalized profit to still grow strongly at 62% year on year, while the current price trades at a PER of 32 times for FY2027. It gives a target price of 4.80 baht per DR, implying 24% upside.
HoonVision·2hRead more →
2

Axcelis Technologies Plans US$35 Million Ion Implantation Plant in Pyeongtaek, Korea

Axcelis Technologies has announced a planned US$35 million ion implantation manufacturing facility in Pyeongtaek, Korea. The capacity move comes as the company's shares have risen 3.5% over one day and 7.4% over seven days, though the stock is down 11% over 30 days and 34% over 90 days, while year-to-date it is up 31.4% and its five-year total shareholder return stands at 127.4%. Axcelis last closed at $113.15, below the $161 fair value cited in the most-followed analyst narrative, which sees the stock as 30% undervalued, while a Simply Wall St discounted cash flow model estimates future cash flow value at just $10.79 per share. The bullish case rests on ongoing R&D and next-generation Purion platform enhancements driving customer engagement in advanced node processes such as trench and super junction devices, but also leans heavily on China exposure and silicon carbide adoption trends that could surprise negatively. Simply Wall St produced the analysis.
Simply Wall St·8hRead more →
impact 4

TSMC Q2 CapEx Hits $15.59 Billion as 2026 Budget Raised a Third Time

TSMC spent $15.59 billion on capital expenditure in its June 2026 quarter, its largest quarterly outlay in the past eight quarters and about 42% above the $10.98 billion spent in the prior quarter, as the company raised its 2026 capital budget for a third time this year, from $52 billion to $56 billion in January, to the high end of that range in April, and to $60 billion to $64 billion in July. On the Q2 2026 earnings call, CFO Wendell Huang guided third quarter gross margin down 170 basis points to 66%, citing 3 to 4 percentage points of dilution from the steep ramp of TSMC's 2 nanometer process, even as the June 2026 quarter's gross margin reached 67.72%, its highest in two years and consistent with the 67.7% figure cited by CEO C.C. Wei. Huang said TSMC generated about $24.5 billion in operating cash flow that quarter, enough to cover the $15.59 billion in CapEx and roughly $4.9 billion in dividends without new borrowing. TSMC is trading at 22.46 times forward normalized earnings, close to its 22.41 times two year average and well below the 29.65 times high in that range, after a mid September selloff tied to AI safety warnings from Anthropic's Dario Amodei and OpenAI's Sam Altman rather than anything specific to TSMC. Institutional 13F filings dated June 30, 2026 show a split Street, with Coatue raising its TSMC stake 7.6% to 9.3 million ADRs and Situational Awareness lifting its position to 2.6 million shares, while Lone Pine cut its stake 92.7%, SoftBank cut 71.5%, and Viking Global cut 29%.
Yahoo Finance·19hRead more →